These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2863779)

  • 41. [GABA receptors and the effect of benzodiazepine].
    Schoch P; Richards JG; Möhler H
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):25-39. PubMed ID: 2431471
    [No Abstract]   [Full Text] [Related]  

  • 42. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The biological basis of benzodiazepine actions.
    Haefely W
    J Psychoactive Drugs; 1983; 15(1-2):19-39. PubMed ID: 6136567
    [No Abstract]   [Full Text] [Related]  

  • 45. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa.
    Sollozo-Dupont I; Estrada-Camarena E; Carro-Juárez M; López-Rubalcava C
    J Ethnopharmacol; 2015 Mar; 162():278-86. PubMed ID: 25582489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebrafish-Involvement of GABAergic and 5-HT systems.
    Benneh CK; Biney RP; Mante PK; Tandoh A; Adongo DW; Woode E
    J Ethnopharmacol; 2017 Jul; 207():129-145. PubMed ID: 28645783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
    Reynolds DS
    Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788.
    File SE; Pellow S
    Neuropsychobiology; 1985; 14(4):193-7. PubMed ID: 2872613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat.
    Brown E'; Hurd NS; McCall S; Ceremuga TE
    AANA J; 2007 Oct; 75(5):333-7. PubMed ID: 17966676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anxiolytic profiles.
    Gershon S; Eison AS
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M; Zarrindast MR; Bina P
    Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skin conductance reaction (SCR)-habituation test, a tool to detect anxiolytic activity. Its justification by the correlation between SCR-habituation test activities and specific binding potencies in benzodiazepines.
    Marcy R; Quermonne MA; Raoul J; Nammathao B; Smida A
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):387-91. PubMed ID: 2866560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?
    Pellow S
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):557-65. PubMed ID: 2877126
    [No Abstract]   [Full Text] [Related]  

  • 57. [Biochemical aspects of anxiety].
    Boulenger JP; Uhde TW
    Sem Hop; 1982 Dec; 58(44):2573-9. PubMed ID: 6130605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [GABA-A receptors: molecular substrate for the development of new anxiolytic agents].
    Obradović D; Savić M; Ugresić N; Bokonjić D
    Vojnosanit Pregl; 2003; 60(3):345-52. PubMed ID: 12891731
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current hypotheses of the central mechanism of action of benzodiazepine tranquilizers].
    Bouchard LP; Llorca PM; Wolf MA
    Can J Psychiatry; 1991 Nov; 36(9):660-6. PubMed ID: 1685351
    [No Abstract]   [Full Text] [Related]  

  • 60. The effects of general anaesthetics on GABAergic synaptic transmission.
    Keane PE; Biziere K
    Life Sci; 1987 Sep; 41(12):1437-48. PubMed ID: 2887996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.